| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Revenue | $4.67B | +3.1% |
| Cost of Revenue | $1.13B | +4.8% |
| Gross Profit | $3.54B | +2.5% |
| R&D Expense | $852.4M | +6.1% |
| SG&A Expense | $442.7M | -23.6% |
| Operating Income | $813.3M | +54.8% |
| Pre-tax Income | $1.32B | +58.1% |
| Income Tax | $305.3M | +56.7% |
| Net Income | $1.01B |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.35B | -13.4% |
| Accounts Receivable | $495.2M | -7.6% |
| Current Assets | $8.68B | +9.5% |
| Total Assets | $10.99B | +10.7% |
| Current Liabilities | $1.90B | +8.0% |
| Total Liabilities | $2.05B | +7.5% |
| Stockholders' Equity | $8.94B | +11.4% |
| Line Item | 2025-01-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.95B | +21.7% |
| Capital Expenditures | $136.6M | +7.6% |
| Investing Cash Flow | -$1.11B | +6.6% |
| Financing Cash Flow | -$1.03B | -1808.2% |
| Free Cash Flow | $1.81B | +22.9% |
| +58.5% |
| EPS (Basic) | $3.28 | +54.7% |
| EPS (Diluted) | $3.21 | +55.1% |